Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Women's Health Rheumatology Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Trial Radar • ClinicalTrials.gov • Registry-linked

Trial Radar

2231 clinical trials with phase, status, specialty and registry links, summarised for rapid clinical review.

2231 recruiting AI clinical summaries
Explore Trial Collections Follow research updates
All Phases Phase I Phase II Phase III Phase IV
Therapeutic Area: All Cardiology / Cardiovascular Dermatology Diabetes / Metabolic Gastroenterology Haematology Infectious Disease Men's Health Mental Health / Psychiatry Nephrology Neurology Oncology Rare Diseases
🔬
Trial Radar

Clinical Trial Intelligence

● Recruiting Phase III Oncology
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) is Recruiting • Phase III • Oncology • NCT06393374.…
02 Apr 2026 NCT06393374
● Recruiting Phase III Respiratory / COPD / Asthma
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids) is Recruiting…
02 Apr 2026 NCT07107945
● Recruiting Phase III Cardiology / Cardiovascular
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) is Recruiting • Phase III • Cardiology / Cardiovascular…
02 Apr 2026 NCT06531824
● Recruiting Phase III Respiratory / COPD / Asthma
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast is…
02 Apr 2026 NCT06238622
● Recruiting Phase III Respiratory / COPD / Asthma
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease is Recruiting • Phase III • Respiratory / COPD / Asthma •…
02 Apr 2026 NCT05595642
● Recruiting Phase III Respiratory / COPD / Asthma
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma is Recruiting • Phase III • Respiratory / COPD / Asthma • NCT06097728.…
02 Apr 2026 NCT06097728
● Recruiting Respiratory / COPD / Asthma
Can Astaxanthin Help Manage Asthma in POlluted Areas?
Can Astaxanthin Help Manage Asthma in POlluted Areas? is Recruiting • Phase not applicable • Respiratory / COPD / Asthma • NCT07507682. This study…
02 Apr 2026 NCT07507682
● Recruiting Phase III Respiratory / COPD / Asthma
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis
The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis is Recruiting • Phase III • Respiratory / COPD…
02 Apr 2026 NCT06872892
● Recruiting Phase III Cardiology / Cardiovascular
EASi-PROTKT™ – A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
EASi-PROTKT™ – A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular…
02 Apr 2026 NCT07064473
● Recruiting Phase II Oncology
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or…
02 Apr 2026 NCT04924075
● Recruiting Phase I Oncology
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory…
02 Apr 2026 NCT05091424
● Recruiting Phase I Oncology
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01) is Recruiting • Phase I • Oncology…
02 Apr 2026 NCT06395103
● Recruiting Phase III Oncology
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard Treatment
Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With Advanced Non-small Cell Lung Cancer With HER2 Mutations Compared With Standard…
02 Apr 2026 NCT06151574
● Recruiting Phase II Oncology
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse…
02 Apr 2026 NCT06890884
● Recruiting Phase II Oncology
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously…
02 Apr 2026 NCT07221149
● Recruiting Phase I Oncology
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps…
02 Apr 2026 NCT06324357
● Recruiting Phase III Oncology
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)
A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017) is Recruiting • Phase III • Oncology • NCT06351631. The primary purpose of the…
02 Apr 2026 NCT06351631
active not recruiting Phase III Oncology
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency is Active Not Recruiting • Phase III • Oncology • NCT04493853.…
01 Apr 2026 NCT04493853
active not recruiting Cardiology / Cardiovascular
International Bicuspid Aortic Valve Consortium (BAVCon)
International Bicuspid Aortic Valve Consortium (BAVCon) is Active Not Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT01980797. Review the linked registry…
01 Apr 2026 NCT01980797
active not recruiting Phase IV Oncology
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator
Study to Allow Access to Imatinib for Patients Who Are on Imatinib Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as…
01 Apr 2026 NCT01742299
active not recruiting Phase III
A Study of Zigakibart in Adults With IgA Nephropathy
A Study of Zigakibart in Adults With IgA Nephropathy is Active Not Recruiting • Phase III • NCT05852938. Review the linked registry entry for…
01 Apr 2026 NCT05852938
● Recruiting Phase II
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH)
Interventional Study of Infigratinib in Children < 3 Years Old With Achondroplasia (ACH) is Recruiting • Phase II • NCT07169279. Review the linked registry…
01 Apr 2026 NCT07169279
active not recruiting Phase III
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients
Comparison Between Rituximab Plus Zanubrutinib Versus Rituximab Monotherapy in Untreated SMZL Patients is Active Not Recruiting • Phase III • NCT05735834. Review the linked…
01 Apr 2026 NCT05735834
active not recruiting Phase I / Phase II Cardiology / Cardiovascular
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension
A Study to Learn About the Study Medicine Called PF-07868489 in Healthy Adult People and in People With Pulmonary Arterial Hypertension is Active Not…
01 Apr 2026 NCT06137742
● Recruiting Phase III
A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
A Continuation Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia is Recruiting • Phase III • NCT06948318. Review the linked registry entry…
01 Apr 2026 NCT06948318
● Recruiting Phase III
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC)
A Study to Evaluate the Safety and Efficacy of Oral Nizubaglustat (AZ-3102) in Late-infantile and Juvenile Forms of Niemann-Pick Type C Disease (NPC) is…
01 Apr 2026 NCT07082725
● Recruiting Phase III Neurology
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer’s Disease (ADAGIO-2)
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer’s Disease (ADAGIO-2)…
01 Apr 2026 NCT07011745
● Recruiting Phase II Neurology
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson’s Disease
A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson’s Disease is Recruiting • Phase II • Neurology…
01 Apr 2026 NCT06680830
● Recruiting Phase II Gastroenterology
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver…
01 Apr 2026 NCT06613698
● Recruiting Gastroenterology
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment
A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment is Recruiting…
01 Apr 2026 NCT06447168
● Recruiting Phase II Gastroenterology
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis
A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis is Recruiting…
01 Apr 2026 NCT05050136
● Recruiting Phase III Gastroenterology
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis
Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and Compensated Cirrhosis is Recruiting • Phase III • Gastroenterology • NCT06051617. To Evaluate the Effect…
01 Apr 2026 NCT06051617
● Recruiting Phase III Mental Health / Psychiatry
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS) is Recruiting •…
01 Apr 2026 NCT07220083
● Recruiting Phase III
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS) is Recruiting •…
01 Apr 2026 NCT05935215
● Recruiting Phase III
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) is Recruiting • Phase III • NCT06935357.…
01 Apr 2026 NCT06935357
● Recruiting Phase III Oncology
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma is Recruiting • Phase III •…
01 Apr 2026 NCT07011719
● Recruiting
DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve
DYNAMic Renal Assessment: NOvel Methods to Assess KIDNEY Functional Reserve is Recruiting • Phase not applicable • NCT06572215. This is a feasibility study to…
01 Apr 2026 NCT06572215
● Recruiting Phase III Respiratory / COPD / Asthma
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma…
01 Apr 2026 NCT06023589
● Recruiting Phase III Respiratory / COPD / Asthma
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis is…
01 Apr 2026 NCT07201922
● Recruiting Phase I Respiratory / COPD / Asthma
A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD)
A Study of AIR-001 in Adults With Alpha-1 Antitrypsin Deficiency (AATD) is Recruiting • Phase I • Respiratory / COPD / Asthma • NCT07431112.…
01 Apr 2026 NCT07431112
● Recruiting Phase III Oncology
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint Inhibitor is Recruiting • Phase…
01 Apr 2026 NCT06472245
● Recruiting Phase II Cardiology / Cardiovascular
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489
A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study…
01 Apr 2026 NCT07073820
● Recruiting Cardiology / Cardiovascular
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT05665608. Patients…
01 Apr 2026 NCT05665608
● Recruiting Phase III Cardiology / Cardiovascular
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome
Long-term Safety and Efficacy of Odevixibat in Patients With Alagille Syndrome is Recruiting • Phase III • Cardiology / Cardiovascular • NCT05035030. The purpose…
01 Apr 2026 NCT05035030
● Recruiting Cardiology / Cardiovascular
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women is Recruiting • Phase not applicable • Cardiology / Cardiovascular • NCT04124120.…
01 Apr 2026 NCT04124120
● Recruiting Oncology
Fabry Disease Registry & Pregnancy Sub-registry
Fabry Disease Registry & Pregnancy Sub-registry is Recruiting • Phase not applicable • Oncology • NCT00196742. The Fabry Registry is an ongoing, international multi-center,…
01 Apr 2026 NCT00196742
● Recruiting Phase III Oncology
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma
A Study Comparing Niraparib With Temozolomide in Adult Participants With Newly-diagnosed, MGMT Unmethylated Glioblastoma is Recruiting • Phase III • Oncology • NCT06388733. The…
01 Apr 2026 NCT06388733
● Recruiting Phase I Oncology
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma is Recruiting • Phase I • Oncology • NCT03761108. The…
01 Apr 2026 NCT03761108
● Recruiting Phase II Oncology
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events is Recruiting • Phase II • Oncology • NCT06500884. The purpose of this study…
01 Apr 2026 NCT06500884
● Recruiting Phase I Oncology
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer…
01 Apr 2026 NCT06806852